Your browser doesn't support javascript.
loading
The scaffolding protein NHERF1 regulates the stability and activity of the tyrosine kinase HER2.
Jeong, Jaekwang; VanHouten, Joshua N; Kim, Wonnam; Dann, Pamela; Sullivan, Catherine; Choi, Jungmin; Sneddon, W Bruce; Friedman, Peter A; Wysolmerski, John J.
Afiliação
  • Jeong J; From the Section of Endocrinology and Metabolism, Department of Internal Medicine.
  • VanHouten JN; From the Section of Endocrinology and Metabolism, Department of Internal Medicine.
  • Kim W; From the Section of Endocrinology and Metabolism, Department of Internal Medicine.
  • Dann P; From the Section of Endocrinology and Metabolism, Department of Internal Medicine.
  • Sullivan C; Department of Pediatrics, and.
  • Choi J; Department of Genetics, Yale University School of Medicine, New Haven, Connecticut 06520.
  • Sneddon WB; the Laboratory for GPCR Biology, Department of Pharmacology and Chemical Biology, and.
  • Friedman PA; the Laboratory for GPCR Biology, Department of Pharmacology and Chemical Biology, and.
  • Wysolmerski JJ; Department of Structural Biology,University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261.
J Biol Chem ; 292(16): 6555-6568, 2017 04 21.
Article em En | MEDLINE | ID: mdl-28235801
ABSTRACT
We examined whether the scaffolding protein sodium-hydrogen exchanger regulatory factor 1 (NHERF1) interacts with the calcium pump PMCA2 and the tyrosine kinase receptor ErbB2/HER2 in normal mammary epithelial cells and breast cancer cells. NHERF1 interacts with the PDZ-binding motif in PMCA2 in both normal and malignant breast cells. NHERF1 expression is increased in HER2-positive breast cancers and correlates with HER2-positive status in human ductal carcinoma in situ (DCIS) lesions and invasive breast cancers as well as with increased mortality in patients. NHERF1 is part of a multiprotein complex that includes PMCA2, HSP90, and HER2 within specific actin-rich and lipid raft-rich membrane signaling domains. Knocking down NHERF1 reduces PMCA2 and HER2 expression, inhibits HER2 signaling, dissociates HER2 from HSP90, and causes the internalization, ubiquitination, and degradation of HER2. These results demonstrate that NHERF1 acts with PMCA2 to regulate HER2 signaling and membrane retention in breast cancers.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fosfoproteínas / Neoplasias da Mama / Trocadores de Sódio-Hidrogênio / Receptor ErbB-2 / ATPases Transportadoras de Cálcio da Membrana Plasmática Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fosfoproteínas / Neoplasias da Mama / Trocadores de Sódio-Hidrogênio / Receptor ErbB-2 / ATPases Transportadoras de Cálcio da Membrana Plasmática Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article